Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Clearing Up Confusion on Cytoreductive Nephrectomy in mRCC

Caroline Seymour
Published: Monday, Aug 19, 2019

David D. Thiel, MD

David D. Thiel, MD

The decision of whether or not to recommend cytoreductive nephrectomy to patients with metastatic renal cell carcinoma (mRCC) is much more nuanced than the topline findings of the phase III CARMENA trial suggest, said David D. Thiel, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication